Frexalimab

6 trials 2 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

2 Recruiting

4 Completed trials

1 Sponsors

20 Countries

Phase III

Phase II/III

Phase II

Phase III: 3 Phase II/III: 1 Phase II: 2

Indications tested

Multiple sclerosis 4 Kidney transplant rejection 1 Systemic lupus erythematosus 1

Sponsors using this IMP

Sanofi-Aventis Recherche & Developpement 6

All trials

6 total

A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation Recruiting

2025-521521-33-00 Phase II/III 12 countries Sanofi-Aventis Recherche & Developpement
Non-inferiority study of frexalimab subcutaneous administration compared to intravenous administration in adult participants with multiple s… Recruiting

2024-519304-28-00 Phase III 3 countries Sanofi-Aventis Recherche & Developpement
Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis Ended

2023-504359-29-01 Phase III 13 countries Sanofi-Aventis Recherche & Developpement
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Ended

2024-514343-29-00 Phase III 16 countries Sanofi-Aventis Recherche & Developpement
Efficacy and safety of Frexalimab (SAR441344) in the treatment of Systemic Lupus Erythematosus Ended

2023-508654-26-00 Phase II 4 countries Sanofi-Aventis Recherche & Developpement
Proof-of-concept study for SAR441344 (frexalimab) in relapsing multiple sclerosis. Ended

2024-513527-17-00 Phase II 5 countries Sanofi-Aventis Recherche & Developpement

Showing 1–6 of 6 trials

← All drugs A–Z